Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Hi Tech Pharmacal Co (NASDAQ: HITK) is 15.77%. Hi Tech Pharmacal's ROE for the same period is 15.20%.

The trailing-twelve-month profit margin at Akorn (NASDAQ: AKRX) is 13.81%. Akorn had $40.78 million in total cash for the latest quarter.

The trailing-twelve-month profit margin at Mylan (NASDAQ: MYL) is 9.43%. Mylan's revenue for the same period is $6.80 billion.

The trailing-twelve-month profit margin at Salix Pharmaceuticals (NASDAQ: SLXP) is 8.74%. Salix's ROA for the same period is 7.24%.